What one roof actually buys you
The hormone-clinic model spreading along Bruce B. Downs splits your care into pieces: an evaluation on video with one company, labs somewhere else, medication shipped from a pharmacy you'll never speak to, and monitoring that amounts to a renewal email. Each handoff is a place where something drops, and the person who discovers the dropped piece is usually you, months later, on hold with a company that considers your monitoring somebody else's department.
The flagship setup removes the handoffs. Your evaluation happens in an exam room on Cashford Circle. The blood draw can happen down the hall, since the office does in-house draws, or at a Quest or LabCorp near you if that's easier. Results return to the physician who examined you. Follow-up bloodwork gets scheduled by the same front desk that knows your file, and when a result needs a conversation, the doctor who ordered it is the one calling. Coordination stops being your job. That's the product.
The same address also holds the rest of your medical life if you want it to. Ascend runs full primary care out of the Wesley Chapel office, along with a medically supervised GLP-1 weight loss program, which matters here more than it might seem: weight and testosterone tangle together tightly enough that treating one without at least discussing the other is half a plan. A man from Seven Oaks or Meadow Pointe who starts with a hormone question can consolidate his annual physical and the rest of his primary care in the same building. Nothing requires that. The option existing is the point.
The evaluation, unhurried and in person
First visits run about 45 minutes face to face. Expect real questions: when the change started, what improved and what didn't, how sleep behaves, what training looks like now, which medications are already on board. A focused physical exam follows. The point of all this is that low testosterone is a diagnosis with impostors, and separating them takes a clinician's attention, not an intake form's.
Arrive with homework done and the visit works harder for you. Prior bloodwork from any source, a written medication and supplement list, and honest answers about alcohol and sleep give Dr. Saylor a running start; a vague history buys you a longer differential. And if you've already been on testosterone through another provider, bring those records especially. Evaluating a man mid-therapy is a different task than evaluating one from scratch, and pretending the history doesn't exist helps nobody.
Then the labs get ordered, and the list is deliberately long: morning total testosterone, free testosterone, SHBG, LH, FSH, estradiol, prolactin, CBC, comprehensive metabolic panel, lipid panel, HbA1c, TSH, and PSA where age fits. Between LH, FSH, and prolactin we can tell a testicular problem from a pituitary one. Between TSH and HbA1c we catch the thyroid and metabolic conditions that impersonate low testosterone constantly in this age group.
The impostors we screen for on purpose
That breadth pays off because low T has convincing impersonators, and Wesley Chapel's demographics serve them up daily. An underactive thyroid mimics the fatigue and the body-composition slide almost perfectly. Sleep apnea deserves particular respect around here, both because it independently suppresses testosterone and because testosterone therapy can make it worse, a two-way street that demands screening before treatment rather than apologies after. Depression overlaps the symptom cluster heavily, and since Ascend has a psychiatric team, mood concerns get coordinated care instead of a shrug. Chronic pain that has slowly shut down a man's activity, and visceral weight suppressing his hormone axis from the metabolic side, complete the differential.
Any of those findings can change the plan, sometimes replacing TRT entirely and sometimes running alongside it. A practice that only sells testosterone has no incentive to find them. A family medicine practice has no excuse not to look.
Bloodwork on the mornings that count, twice
Testosterone peaks early in the day, so draws happen between 7 and 10 a.m., full stop, no matter how inconvenient the calendar finds that biology. And a single low value doesn't buy a prescription. Levels vary enough from day to day that the guideline standard, and ours, is confirmation on a second, separate morning before any treatment decision. The in-house draw makes this less annoying than it sounds: two early stops at an office you can reach without planning your week around it, coordinated by people who already have your chart open.
We hold the two-draw line because the alternative fails men in both directions. Prescribe off one number and some men start a controlled hormone they never needed. Dismiss off one number and some men with genuine hypogonadism get told they're fine. The second morning fixes both errors for the cost of one more needle.
The part where we talk about Schedule III
Testosterone is a Schedule III controlled substance under federal law, and that sentence should appear prominently on any page selling you testosterone therapy, so here it is on ours. Schedule III status is why we require the initial evaluation in person here, why the diagnosis must be documented in bloodwork rather than symptoms alone, why the prescription is conditional on follow-up, and why no legitimate program lets refills run on autopilot. The medication meaningfully affects red blood cell production, fertility, and sleep-disordered breathing, which is precisely the profile of drug the controlled-substance framework was built to supervise.
Treat this as a consumer test. If a clinic's marketing never mentions the scheduling, or its process is incompatible with it, you've learned what you needed to know before spending a dollar of your time there.
Worth spelling out for anyone comparing options in Pasco County: the scheduling isn't a hurdle we invented to seem thorough. It's federal law applying equally to every clinic on every corridor, and the operations that skip confirmatory lab work altogether aren't offering a shortcut worth taking. Now you do.
Choosing a route, and what we won't promise
With hypogonadism confirmed on two draws, treatment becomes a menu with trade-offs rather than a default. Injectable testosterone cypionate or enanthate, intramuscular or subcutaneous, typically weekly or twice weekly, gives the most control. Topical gels trade needles for daily application and transfer precautions. Pellets trade flexibility for infrequency. Fertility gets decided before any of it, because exogenous testosterone suppresses the LH and FSH signals that drive sperm production, recovery after stopping is common but not guaranteed, and men with family plans need to hear about preserving alternatives first.
On results, we'll tell you what the evidence supports: many men with confirmed deficiency experience meaningful improvement in energy, libido, and body composition over months of properly dosed therapy. Some don't. Anyone promising you a specific transformation is marketing, not practicing medicine, and this practice won't do it.
Whose name is on the prescription
Dr. Jason Saylor, DO, board-certified in family medicine through the osteopathic pathway and seventeen years into practice, is Ascend's Chief Medical Officer and the prescriber for this program. His scope covers the whole terrain a testosterone case actually occupies: men's health, hormone evaluation, weight loss management, preventive medicine, and chronic disease management. He works out of the Cashford Circle office in person and covers established patients across Florida by telehealth.
The flagship arrangement gives that fact extra weight. At satellite-style operations, the person who evaluates you, the person who reads your labs, and the person who fields your three-month questions can be three different people employed by two different companies. Here they're all the same physician, in the same building where your blood was drawn, and if you bump into a question between visits, the front desk that answers (813) 670-3331 can put your chart in front of the person who wrote the prescription rather than a call-center script.
Monitoring is the program, not an add-on
The prescription begins a schedule, and the schedule is the substance of the program. Bloodwork returns at three months, again at six, then every six to twelve months for as long as therapy runs. We're tracking hormone levels against target, watching hematocrit because testosterone can push red cell counts into risky territory, following PSA where appropriate, and staying alert to sleep apnea getting worse. Dose, frequency, and route all get adjusted off this data. Established patients can shift the conversation portion of these visits to Florida telehealth, with the draws done in-house on Cashford Circle or at a collection site near home, whichever your calendar prefers. What we don't do is let the calendar lapse while the refills continue. On a Schedule III hormone, that's not a service model, it's negligence with a subscription price.
The one-roof advantage shows up most clearly right here, years into therapy. Your monitoring history lives in a single chart at a single office, so a hematocrit that has crept upward across three draws gets seen as a trend rather than three disconnected snapshots. Men who split their care across a lab company, a telehealth platform, and a shipping pharmacy rarely have anyone positioned to notice that pattern. And when an adjustment is warranted, it happens in a conversation with the physician who has your whole file, sometimes over video, sometimes across a desk on Cashford Circle, followed by a recheck the front desk books before you hang up or walk out. Boring, procedural, unglamorous. Also the entire difference between hormone therapy done as medicine and hormone therapy done as retail.
Insurance, self-pay, and one phone number
Dr. Saylor is in-network with Aetna, ChampVA, and UnitedHealthcare, and benefits get verified before any prescription decision. Lab work is generally covered by most plans; the medication side depends on your plan and the route you land on. Self-pay works too, priced by visit type and lab scope rather than a one-size bundle, which is why real numbers come from the billing team at (813) 670-3331 instead of a webpage estimate. That's also the number for scheduling: most new patients are seen within one to two weeks, same-week slots open regularly, and the realistic distance from first call to a prescription decision, with both lab mornings done, is about three to four weeks.
A last word on the subscription comparison, since it always comes up on the phone. Flat monthly bundles look tidy until you notice what the flat fee tends to exclude, or what it quietly includes that your case never needed. Itemized medicine billed through insurance where possible isn't as slick a pitch, but it means you pay for the care your labs actually justify, and nothing else.
Who we work with in Wesley Chapel & nearby Pasco
The Wesley Chapel office is the closest in-person option for most of central and northern Pasco County:
- Wesley Chapel: 33544, 33543, 33545 (Seven Oaks, Meadow Pointe, Saddlebrook)
- Land O' Lakes: 34637, 34638, 34639
- Lutz: 33549, 33558
- Zephyrhills: 33540, 33541, 33542
- Trinity: 34655
- San Antonio & Dade City: 33576, 33523, 33525
- New Tampa & Tampa Palms: 33647 (closer to WC than to Carrollwood for some addresses)
Also see our nearby men's health options
- TRT in Tampa: in-person at our Carrollwood office, ~25 min south via I-75
- TRT in Brandon: Florida telehealth, for men in Brandon, Valrico, Riverview
- Men's health pillar: full program detail, FAQs, and clinical workup
- GLP-1 weight loss in Wesley Chapel: when weight is part of the picture
- Wesley Chapel primary care: for everything beyond hormone work
FAQs about TRT in Wesley Chapel
Where is the Wesley Chapel TRT office?
27724 Cashford Circle, Suite 102, Wesley Chapel, FL 33544. Just off Highway 56, near The Shops at Wiregrass and AdventHealth Wesley Chapel. Surface parking, accessible entrance, in-house lab draw available. Florida telehealth follow-ups also available for established patients. Testosterone is a controlled medication (Schedule III); we prescribe it only after an in-person evaluation and lab workup, with required follow-up and monitoring.
What labs are involved in the workup?
Morning total testosterone, free testosterone, SHBG, LH, FSH, estradiol, prolactin, CBC, comprehensive metabolic panel, lipid panel, HbA1c, TSH, and PSA when age-appropriate. Drawn between 7 and 10 a.m. when testosterone peaks. If the first draw shows low T, we repeat on a separate morning. Two confirmatory draws is standard before any prescription.
How fast can I get an appointment?
Most new TRT patients get scheduled within one to two weeks. Same-week appointments happen when slots open. Call (813) 670-3331 first thing in the morning if you need a faster slot. Lab work usually happens before the second visit, so the timeline from first call to first prescription decision is roughly three to four weeks.
Will TRT affect my fertility?
Yes, often substantially. Exogenous testosterone suppresses LH and FSH, which suppresses sperm production. Effects can be reversible after discontinuation but sometimes are not, particularly with longer therapy. If fertility is on your radar, we discuss it before any TRT decision and consider alternatives that preserve testicular function.
What if I just want a script and not a workup?
That's not what we do. TRT done correctly requires lab confirmation, contraindication screening, and ongoing monitoring. There are TRT clinics in Wesley Chapel that will write the prescription faster - that's their model. Ours is family medicine.
Do you take insurance?
In-network with Aetna, ChampVA, and UnitedHealthcare today. Lab work is generally covered by most plans. The medication itself depends on your plan and the route selected.
TRT is a prescription medication for clinically diagnosed hypogonadism and requires lab confirmation, prescriber supervision, and ongoing monitoring. Possible side effects include increased red blood cell count, fertility suppression, sleep apnea worsening, and other clinically significant effects. Individual results vary. This page is informational and does not substitute for a clinical visit. Bhasin S et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." J Clin Endocrinol Metab. 2018;103(5):1715-1744. See also FDA prescribing information for testosterone products via FDA Drugs@FDA.